Shares of Moderna Inc. (NASDAQ: MRNA) have gained 246% since the beginning of this year and more than 279% over the past
Moderna Inc
-(MRNA)
COVID-19 vaccine development: A look at some of the pharma companies and their progress
The COVID-19 pandemic continues to go on and while the world is slowly coming out of the previously imposed strict lockdown, things
Moderna, Inc. (MRNA) Q2 2020 Earnings Conference Call Transcript
Moderna Inc. (NASDAQ: MRNA) Q2 2020 earnings call dated Aug. 05, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane Bancel -- Chief Executive
Moderna impresses on the financial side as well in Q2
Moderna, Inc., (Nasdaq: MRNA), a prime contender in Covid-19 vaccine research, on Wednesday, reported second-quarter financial results that smashed past analysts’ estimates.
Moderna Inc (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call Transcript
Moderna Inc (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call dated July 15, 2020 Corporate Participants: Lavina Talukdar -- Head
Moderna medical chief: Varying infection rate to be the biggest challenge in Phase 3
A diverse population with varying infection rates will be among the biggest challenges during the phase 3 trials of its COVID-19 vaccine
Rallies you may have missed: 6 stocks that soared in 2020
This year, we saw long red candles replacing clowns as the ultimate symbol of horror. It has given sleepless nights to not
Moderna Inc (NASDAQ: MRNA) Q1 2020 Earnings Call Transcript
Moderna Inc (MRNA) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations Stephane Bancel -- Chief Executive Officer
Moderna (NASDAQ: MRNA) SARS-CoV-2 Vaccine Interim Phase 1 Data Call Transcript
Moderna Inc (MRNA) Q1 2019 interim phase 1 data conference call dated May. 18, 2020 Corporate Participants: Lavina Talukdar -- Head of Investor Relations